CClinicalTrials.gg
CompletedNCT02680210IDENTITYUpdated May 13, 2019

Self-defining Memories in Patients With a TBI

An interventional study of Questionnaires and cognitive measures in Traumatic Brain Injuries, Neurobehavioral Manifestations and Cognition Disorders, sponsored by Centre d'Investigation Clinique et Technologique 805. Completed at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-05-13.

Sponsored by Centre d'Investigation Clinique et Technologique 805 · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The study will be conducted over 18 months. The main objective of this study is to explore the relationships between autobiographical memory and specific cognitive measures, as well as emotional and behavioural measures in patients who have suffered a moderate to severe TBI. Secondary objectives are to assess the psychometric properties of a self-defining memories questionnaire and to characterize autobiographical memory in the TBI population.

Read the detailed description

A total of 40 participants (20 non-consecutive adults with a moderate or severe TBI and 20 volunteers with any history of neurological or psychiatric disease) will be recruited into the study. The duration of the protocol is 70 minutes. As regards the assessment, three questionnaires will be administered in order to evaluate self-defining memories, apathetic manifestations and anxio-depressive symptoms. In addition, four cognitive measures will be used to assess verbal episodic memory, working memory, cognitive flexibility and verbal fluency.

02

Conditions studied

  • Traumatic Brain Injuries
  • Neurobehavioral Manifestations
  • Cognition Disorders
  • Memory Deficits
03

In context

Brain Injuries

2,113 studies on the registry are indexed under Brain Injuries; 385 are open to participants now.

This study's enrollment of 32 is below the median of 48 across 1,331 interventional studies indexed under Brain Injuries.

Browse Brain Injuries studies →

Lead sponsor

Centre d'Investigation Clinique et Technologique 805 is the lead sponsor of 74 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • patients with a moderate or severe TBI occurred at least 6 months ago (initial Glasgow Coma Scale score ≤ 12 or post-traumatic amnesia duration > 1 week)
  • patients ≥ 18 years old and who have signed a letter of information

Exclusion criteria

Exclusion Criteria:

  • history of neurological and/or psychiatric disease
  • persistent motor, sensitive and instrumental disorders that could disturb the efficient evaluation of the participant
  • patients who refused to participate in the study
  • non affiliation to a social security scheme
  • patients under guardianship or trusteeship
  • pregnant woman
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
32 participants (actual)

Study arms

  • Other
    cognitive measures and questionnaires

    the material of the study will consist of cognitive measures and questionnaires in order to (1) compare the cognitive performances and behavioral manifestations between patients with TBI and volunteers without neurological disorders and (2) to analyze the links between cognitive and behavioural measures in the TBI population

    Other: Questionnaires and cognitive measures

Interventions

  • OtherQuestionnaires and cognitive measures
06

What researchers measure

Primary outcomes

  1. self-defining memory score

    self-defining memories will be measured using the self-defining memories questionnaire

    Time frame: 20 minutes

Secondary outcomes

  1. verbal episodic memory score

    verbal episodic memory will be measured using the California Verbal Learning Test

    Time frame: 20 minutes

  2. working memory score

    working memory will be measured using verbal span task

    Time frame: 10 minutes

  3. cognitive flexibility score

    cognitive flexibility will be measured using the Trail Making Test

    Time frame: 5 minutes

  4. verbal fluency score

    verbal fluency will be measured using the verbal fluency task

    Time frame: 5 minutes

  5. apathy score

    apathetic manifestations will be measured using the Apathy Evaluation Scale

    Time frame: 5 minutes

  6. anxio-depressive score

    anxio-depressive symptoms will be measured using the Hospital Anxiety and Depression Scale

    Time frame: 5 minutes

07

Study locations

1 site
  • Hôpital Raymond Poincaré
    Garches, Ile De France 92380, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 13, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02680210
Lead sponsor
Centre d'Investigation Clinique et Technologique 805
Responsible party
AZOUVI (Principal investigator, Centre d'Investigation Clinique et Technologique 805) — Principal investigator
First posted
Feb 11, 2016
Start date
Feb 4, 2016
Primary completion
May 2016
Completion
May 2016
Last update
May 13, 2019

Study contacts

Annabelle Arnould, psychologue
study chair · Hôpital Raymond Poincaré

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion